Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Ekso Bionics Holdings (EKSO) Shares Outstanding (Diluted Average) (2016 - 2023)

Historic Shares Outstanding (Diluted Average) for Ekso Bionics Holdings (EKSO) over the last 11 years, with Q1 2023 value amounting to $13.3 million.

  • Ekso Bionics Holdings' Shares Outstanding (Diluted Average) rose 446.26% to $13.3 million in Q1 2023 from the same period last year, while for Mar 2023 it was $13.3 million, marking a year-over-year increase of 446.26%. This contributed to the annual value of $13.0 million for FY2022, which is 564.84% up from last year.
  • According to the latest figures from Q1 2023, Ekso Bionics Holdings' Shares Outstanding (Diluted Average) is $13.3 million, which was up 446.26% from $13.0 million recorded in Q4 2022.
  • Ekso Bionics Holdings' Shares Outstanding (Diluted Average)'s 5-year high stood at $13.3 million during Q1 2023, with a 5-year trough of $5.0 million in Q3 2019.
  • In the last 5 years, Ekso Bionics Holdings' Shares Outstanding (Diluted Average) had a median value of $12.7 million in 2021 and averaged $10.8 million.
  • Per our database at Business Quant, Ekso Bionics Holdings' Shares Outstanding (Diluted Average) tumbled by 9185.9% in 2019 and then skyrocketed by 10343.4% in 2021.
  • Quarter analysis of 5 years shows Ekso Bionics Holdings' Shares Outstanding (Diluted Average) stood at $5.0 million in 2019, then skyrocketed by 43.37% to $7.2 million in 2020, then skyrocketed by 71.26% to $12.3 million in 2021, then increased by 5.65% to $13.0 million in 2022, then increased by 2.58% to $13.3 million in 2023.
  • Its Shares Outstanding (Diluted Average) was $13.3 million in Q1 2023, compared to $13.0 million in Q4 2022 and $13.1 million in Q3 2022.